Dr Grayson K Rodgers, MD in Birmingham, AL - Medicare Otolaryngology

Dr Grayson K Rodgers, MD is a medicare enrolled "Otolaryngology - Otology & Neurotology" physician in Birmingham, Alabama. He went to University Of North Carolina At Chapel Hill School Of Medicine and graduated in 1986 and has 38 years of diverse experience with area of expertise as Otolaryngology. He is a member of the group practice Alabama Ear Pc and his current practice location is 2700 10th Ave S Ste 502, Birmingham, Alabama. You can reach out to his office (for appointments etc.) via phone at (205) 933-2951.

Dr Grayson K Rodgers is licensed to practice in Alabama (license number 00016561) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1033228242.

Contact Information

	Dr Grayson K Rodgers, MD
	2700 10th Ave S Ste 502, Birmingham, AL 35205-1250
	(205) 933-2951
	(205) 933-5893

Physician's Profile

Full Name	Dr Grayson K Rodgers
Gender	Male
Speciality	Otolaryngology
Experience	38 Years
Location	2700 10th Ave S Ste 502, Birmingham, Alabama
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Grayson K Rodgers attended and graduated from University Of North Carolina At Chapel Hill School Of Medicine in 1986

NPI Data:

NPI Number: 1033228242
Provider Enumeration Date: 08/30/2006
Last Update Date: 02/09/2010

Medicare PECOS Information:

PECOS PAC ID: 3072671627
Enrollment ID: I20081025000142

Medical Identifiers

Medical identifiers for Dr Grayson K Rodgers such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1033228242	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207YX0901X	Otolaryngology - Otology & Neurotology	00016561 (Alabama)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
St Vincent's Birmingham	Birmingham, AL	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Alabama Ear Pc	1052642576	3

News Archive

As coronavirus spreads widely, millions of older Americans live in counties with no ICU beds

More than half the counties in America have no intensive care beds, posing a particular danger for more than 7 million people who are age 60 and up - older patients who face the highest risk of serious illness or death from the rapid spread of COVID-19, a Kaiser Health News data analysis shows.

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons' open new path to femtomedicine

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons' has opened up the path to femtomedicine, an entirely new cancer diagnostics, it was reported today at First Global Congress on NanoEngineering for Medicine and Biology in Houston, TX.

Cogstate technology to be applied in paediatric clinical trial in the U.S.

Medical technology company Cogstate Limited has today announced its technology will be used in a large paediatric clinical trial in the United States.

Digna Biotech receives FDA Orphan Drug status for cardiotrophin-1 to treat ALF

Digna Biotech, a Spanish biotechnological company, announces that the Food and Drug Administration (FDA) granted cardiotrophin-1 (CT-1) Orphan Drug status for use in the treatment of acute liver failure.

Novel C. elegans worm strain could serve as tool for testing interventions against AD

Researchers from Yale-NUS College have partnered with researchers from the National University of Singapore and SingHealth Group to develop a novel Caenorhabditis elegans (C. elegans) worm strain which expresses an amyloid beta protein fragment involved in the development of human Alzheimer's Disease (AD).

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Grayson K Rodgers allows following entities to bill medicare on his behalf.

Entity Name	Alabama Ear Pc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1700346624 PECOS PAC ID: 1052642576 Enrollment ID: O20191015002481

News Archive

As coronavirus spreads widely, millions of older Americans live in counties with no ICU beds

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons' open new path to femtomedicine

Cogstate technology to be applied in paediatric clinical trial in the U.S.

Medical technology company Cogstate Limited has today announced its technology will be used in a large paediatric clinical trial in the United States.

Digna Biotech receives FDA Orphan Drug status for cardiotrophin-1 to treat ALF

Novel C. elegans worm strain could serve as tool for testing interventions against AD

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Grayson K Rodgers is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Grayson K Rodgers, MD 2700 10th Ave S Ste 502, Birmingham, AL 35205-1250 Ph: (205) 933-2951	Dr Grayson K Rodgers, MD 2700 10th Ave S Ste 502, Birmingham, AL 35205-1250 Ph: (205) 933-2951

News Archive

As coronavirus spreads widely, millions of older Americans live in counties with no ICU beds

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons' open new path to femtomedicine

Cogstate technology to be applied in paediatric clinical trial in the U.S.

Medical technology company Cogstate Limited has today announced its technology will be used in a large paediatric clinical trial in the United States.

Digna Biotech receives FDA Orphan Drug status for cardiotrophin-1 to treat ALF

Novel C. elegans worm strain could serve as tool for testing interventions against AD

Otolaryngology Doctors in Birmingham, AL

Dr. Jessica Warren Grayson, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011
Brian Kulbersh, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1940 Elmer J Bissell Rd, Birmingham, AL 35243 Phone: 205-638-4949 Fax: 205-638-4982
Dr. Richard Kailean Mchugh, MD, PHD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, The Kirklin Clinic, Birmingham, AL 35233 Phone: 205-801-8000
Paul F Castellanos, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600
Dr. David Michael Walters, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1809 Gadsden Hwy, Birmingham, AL 35235 Phone: 205-838-3755 Fax: 205-838-3755
Do Yeon Cho, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, Birmingham, AL 35233 Phone: 205-934-9999

Dr Grayson K Rodgers, MD - Medicare Otolaryngology in Birmingham, AL

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

As coronavirus spreads widely, millions of older Americans live in counties with no ICU beds

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons' open new path to femtomedicine

Cogstate technology to be applied in paediatric clinical trial in the U.S.

Digna Biotech receives FDA Orphan Drug status for cardiotrophin-1 to treat ALF

Novel C. elegans worm strain could serve as tool for testing interventions against AD

Medicare Reassignments

As coronavirus spreads widely, millions of older Americans live in counties with no ICU beds

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons' open new path to femtomedicine

Cogstate technology to be applied in paediatric clinical trial in the U.S.

Digna Biotech receives FDA Orphan Drug status for cardiotrophin-1 to treat ALF

Novel C. elegans worm strain could serve as tool for testing interventions against AD

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

As coronavirus spreads widely, millions of older Americans live in counties with no ICU beds

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons' open new path to femtomedicine

Cogstate technology to be applied in paediatric clinical trial in the U.S.

Digna Biotech receives FDA Orphan Drug status for cardiotrophin-1 to treat ALF

Novel C. elegans worm strain could serve as tool for testing interventions against AD

Otolaryngology Doctors in Birmingham, AL